We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+6.79%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$815M
AUM Growth
+$71.6M
Cap. Flow
+$21.9M
Cap. Flow %
2.68%
Top 10 Hldgs %
64.64%
Holding
147
New
20
Increased
66
Reduced
21
Closed
11

Sector Composition

Rank Sector Weight
1 Financials 4.05%
2 Technology 1.18%
3 Industrials 0.94%
4 Healthcare 0.91%
5 Consumer Staples 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRIP icon
76
TripAdvisor
TRIP
$1.7B
$477K 0.06%
6,296
+10
+0.2% +$708
ECYT
77
DELISTED
Endocyte, Inc. Common Stock
ECYT
$476K 0.06%
35,732
MMM icon
78
3M
MMM
$91.8B
$474K 0.06%
4,741
+518
+12% +$50.4K
PM icon
79
Philip Morris
PM
$309B
$454K 0.06%
5,241
+2,069
+65% +$181K
WBA
80
DELISTED
Walgreens Boots Alliance
WBA
$442K 0.05%
8,214
WMB icon
81
Williams Companies
WMB
$85.8B
$434K 0.05%
11,940
+1,880
+19% +$65.9K
AMZN icon
82
Amazon
AMZN
$2.44T
$431K 0.05%
27,600
+6,600
+31% +$98.4K
QQQ icon
83
Invesco QQQ Trust
QQQ
$436B
$424K 0.05%
5,372
SRCL
84
DELISTED
Stericycle Inc
SRCL
$422K 0.05%
3,657
BAC icon
85
Bank of America
BAC
$429B
$414K 0.05%
29,946
+9,609
+47% +$137K
TD icon
86
Toronto Dominion Bank
TD
$193B
$409K 0.05%
9,080
+142
+2% +$6.04K
ORCL icon
87
Oracle
ORCL
$339B
$401K 0.05%
12,102
+3,346
+38% +$109K
ADI icon
88
Analog Devices
ADI
$172B
$394K 0.05%
+8,372
New +$400K
USB icon
89
US Bancorp
USB
$97.9B
$392K 0.05%
10,741
+3,226
+43% +$119K
GILD icon
90
Gilead Sciences
GILD
$165B
$391K 0.05%
6,217
+2,057
+49% +$123K
MGV icon
91
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.1B
$391K 0.05%
7,770
WMT icon
92
Walmart Inc
WMT
$909B
$386K 0.05%
15,642
+6,045
+63% +$152K
CAT icon
93
Caterpillar
CAT
$361B
$384K 0.05%
4,599
+581
+14% +$49.1K
COP icon
94
ConocoPhillips
COP
$144B
$378K 0.05%
5,441
+1,046
+24% +$69.8K
TGT icon
95
Target
TGT
$66.3B
$378K 0.05%
5,899
-157
-3% -$10.7K
SLB icon
96
SLB Ltd
SLB
$72.7B
$377K 0.05%
4,263
+905
+27% +$74.4K
EMC
97
DELISTED
EMC CORPORATION
EMC
$374K 0.05%
14,641
+2,944
+25% +$76.5K
VUG icon
98
Vanguard Morningstar Growth ETF
VUG
$212B
$367K 0.05%
26,040
NKE icon
99
Nike
NKE
$64.1B
$364K 0.04%
10,010
+542
+6% +$17.7K
SYK icon
100
Stryker
SYK
$135B
$363K 0.04%
5,363
+300
+6% +$20.7K

Similar funds

Ballentine Partners's Q3 2013 Portfolio in Review

As of Q3 2013, Ballentine Partners held 147 positions worth $815M, up 9.6% from $744M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Ballentine Partners's Q3 2013 filing shows 20 new, 66 increased, 21 reduced and 11 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 19,175 shares worth $1.1M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $14.3M.

By sector, the portfolio is most concentrated in Financials at 4.1% of assets, up from 4% a quarter earlier, followed by Technology and Industrials.

  • Ballentine Partners's largest Q3 2013 buy was iShares Core MSCI EAFE ETF: 19,175 shares worth $1.1M.
  • Ballentine Partners added most to iShares Core MSCI Emerging Markets ETF in Q3 2013, an estimated $18.5M increase.
  • Ballentine Partners's biggest Q3 2013 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $14.3M.
  • Ballentine Partners fully exited Antares Pharma, Inc. in Q3 2013, selling an estimated $499K.
  • Ballentine Partners's ten largest holdings make up 65% of its $815M portfolio in Q3 2013.
  • Ballentine Partners opened 20 new positions and closed 11 in Q3 2013.
  • Ballentine Partners's portfolio value rose 9.6% quarter-over-quarter to $815M.

Based on Ballentine Partners's 13F filing for Q3 2013, filed 29 Oct 2013.